annb0t
Top 20
Creso Pharma (ASX:CPH) Full Year 2022 Results
Key Financial Results
Revenue: AU$9.03m (up 45% from FY 2021). Net loss: AU$32.8m (loss widened by 9.2% from FY 2021). AU$0.022 loss per share. earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
Creso Pharma shares are down 13% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Creso Pharma (3 are a bit concernin...
>>> Read more: Creso Pharma Full Year 2022 Earnings: AU$0.022 loss per share (vs AU$0.027 loss in FY 2021)
Key Financial Results
Revenue: AU$9.03m (up 45% from FY 2021). Net loss: AU$32.8m (loss widened by 9.2% from FY 2021). AU$0.022 loss per share. earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
Creso Pharma shares are down 13% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Creso Pharma (3 are a bit concernin...
>>> Read more: Creso Pharma Full Year 2022 Earnings: AU$0.022 loss per share (vs AU$0.027 loss in FY 2021)
